3D printing is transforming healthcare by providing customized and affordable medical components such as prostheses and implants. This technology enables surgeons to work more efficiently with tools and models specifically designed for individual patients, while also allowing medical device manufacturers to develop new products more quickly. Additionally, 3D printed tissues have the potential to enhance drug research and development, which could lead to lower costs and greater accessibility to medications. In the realm of education, 3D printing offers realistic anatomical models that improve hands-on learning experiences compared to traditional models. This paper reviews the role of 3D printing and bio-printing in healthcare, outlining the necessary steps for implementation and the facilities that support this technology. It also highlights significant applications of 3D printing in the medical field, demonstrating its potential to improve patient care and medical training.

Breast cancer is a type of cancer that creates in the cells of the breast. It happens when cells in the breast grow uncontrollably and form a mass or lump. These cancerous cells can attack nearby tissues and, in advanced stages, may spread to other parts of the body through the bloodstream or lymphatic system in this article breast cancer and its etiology and classification are discussed.
Breast cancer, a globally significant health concern, exhibits an increasing incidence worldwide, with over 7 million annual deaths. This paper delves into its prevalence, impact on mortality, risk factors, and research focus. Breast cancer, most prevalent among women, necessitates a thorough understanding for effective prevention, diagnosis, and treatment. The etiology involves age, hormone levels, race, economic status, and viral involvement. The classification encompasses histological and molecular perspectives, detailing subtypes like Luminal, HER2-enriched, Basal-like, and Claudin-Low. Molecular assays aid risk stratification, and the AJCC Classification incorporates biological factors. Understanding histological and molecular subtypes is crucial for tailored treatment and prognosis prediction. The historical context traces breast cancer back thousands of years, with detailed documentation emerging in the 17th century. Surgical interventions dominated the early 20th century, evolving towards less invasive procedures and nuanced understandings. The mid-20th century introduced mammography for early detection, significantly impacting survival rates. Advances in the late 20th and early 21st centuries include targeted therapies, genetic testing, and awareness campaigns. While progress has been made, challenges persist, emphasizing the continuous nature of the outbreak marked by scientific discoveries, medical advancements, and societal efforts against this impactful disease.